ERBB2

E261825

ERBB2, also known as HER2, is a receptor tyrosine kinase frequently overexpressed in certain breast and other cancers and serves as a key therapeutic target.

All labels observed (12)

How this entity was disambiguated

Statements (70)

Predicate Object
instanceOf human gene ⓘ
protein-coding gene ⓘ
proto-oncogene ⓘ
receptor tyrosine kinase ⓘ
activationMechanism heterodimerization with other ERBB receptors ⓘ
associatedWithDisease HER2-positive breast cancer ⓘ
bladder cancer ⓘ
breast cancer ⓘ
colorectal cancer ⓘ
endometrial cancer ⓘ
gastric adenocarcinoma ⓘ
gastric cancer ⓘ
gastroesophageal junction cancer ⓘ
lung cancer ⓘ
ovarian cancer ⓘ
salivary gland carcinoma ⓘ
biologicalProcess cell differentiation ⓘ
cell proliferation ⓘ
epidermal growth factor receptor signaling pathway ⓘ
phosphorylation ⓘ
protein autophosphorylation ⓘ
regulation of cell growth ⓘ
signal transduction ⓘ
cellularComponent cell surface ⓘ
integral component of membrane ⓘ
plasma membrane ⓘ
clinicalBiomarkerFor selection of anti-HER2 therapy ⓘ
encodes HER2 protein ⓘ
linked to: HER2 receptor

NEU proto-oncogene protein ⓘ
linked to: HER2 receptor

Receptor tyrosine-protein kinase erbB-2 ⓘ
linked to: ERBB2
ensemblId ENSG00000141736 ⓘ
entrezGeneId 2064 ⓘ
formsHeterodimerWith EGFR (ERBB1) ⓘ
linked to: EGFR

ERBB3 ⓘ
ERBB4 ⓘ
genomicAlteration gene amplification ⓘ
overexpression ⓘ
hasDomain extracellular ligand-binding domain ⓘ
intracellular tyrosine kinase domain ⓘ
single-pass transmembrane domain ⓘ
hasSynonym CD340 ⓘ
ERBB2 oncogene ⓘ
ERBB2 proto-oncogene ⓘ
linked to: ERBB2

ERBB2 receptor tyrosine kinase ⓘ
linked to: ERBB2

HER2 ⓘ
linked to: ERBB2

NEU ⓘ
p185HER2 ⓘ
linked to: ERBB2
locatedOnChromosome chromosome 17 ⓘ
locatedOnChromosomeArm 17q12 ⓘ
memberOf EGFR family ⓘ
ERBB receptor family ⓘ
molecularFunction ATP binding ⓘ
protein heterodimerization activity ⓘ
protein tyrosine kinase activity ⓘ
organism Homo sapiens ⓘ
overexpressedIn HER2-positive breast tumors ⓘ
some gastric tumors ⓘ
pathway ERBB signaling pathway ⓘ
MAPK signaling pathway ⓘ
PI3K-AKT signaling pathway ⓘ
receptorType ligand-less co-receptor ⓘ
therapeuticTargetOf ado-trastuzumab emtansine (T-DM1) ⓘ
fam-trastuzumab deruxtecan ⓘ
lapatinib ⓘ
neratinib ⓘ
pertuzumab ⓘ
trastuzumab ⓘ
linked to: Herceptin

tucatinib ⓘ
uniprotId P04626 ⓘ
usedIn molecular subtyping of breast cancer ⓘ

How these facts were elicited

Referenced by (31)

Full triples — surface form annotated when it differs from this entity's canonical label.

Herceptin → bindsTo → human epidermal growth factor receptor 2 ⓘ
linked to: ERBB2
Herceptin → antibodyTarget → ERBB2 ⓘ
Perjeta → hasTarget → ERBB2 ⓘ
HER2 receptor → hasAlternativeName → HER-2/neu ⓘ
linked to: ERBB2
HER2 receptor → encodedByGene → ERBB2 gene ⓘ
linked to: ERBB2
HER2 receptor → memberOf → ERBB receptor family ⓘ
linked to: ERBB2
ERBB2 → encodes → Receptor tyrosine-protein kinase erbB-2 ⓘ
linked to: ERBB2
ERBB2 → hasSynonym → HER2 ⓘ
linked to: ERBB2
ERBB2 → hasSynonym → ERBB2 proto-oncogene ⓘ
linked to: ERBB2
ERBB2 → hasSynonym → ERBB2 receptor tyrosine kinase ⓘ
linked to: ERBB2
ERBB2 → hasSynonym → p185HER2 ⓘ
linked to: ERBB2
pertuzumab → targets → ERBB2 ⓘ
CD340 → alternativeNameOf → human epidermal growth factor receptor 2 ⓘ
linked to: ERBB2
CD340 → alternativeNameOf → HER2 ⓘ
linked to: ERBB2
CD340 → alternativeNameOf → ERBB2 ⓘ
CD340 → encodes → ERBB2 gene ⓘ
linked to: ERBB2
ERBB3 → formsHeterodimerWith → ERBB2 (HER2) ⓘ
linked to: ERBB2
lapatinib → targets → ERBB2 ⓘ
lapatinib → targets → HER2 ⓘ
linked to: ERBB2
neratinib → targets → ERBB2 ⓘ
neratinib → targets → HER2 ⓘ
linked to: ERBB2
tucatinib → targets → HER2 ⓘ
linked to: ERBB2
tucatinib → targets → ERBB2 ⓘ
CLEOPATRA trial → targetMolecule → HER2 ⓘ
linked to: ERBB2
CLEOPATRA trial → trastuzumabTarget → HER2 extracellular domain ⓘ
linked to: ERBB2
CLEOPATRA → target → human epidermal growth factor receptor 2 ⓘ
linked to: ERBB2
epidermal growth factor receptor family → hasMember → HER2 ⓘ
linked to: ERBB2